Skip To Main Content

Choose Confidently Choose Cerezyme

when considering an ERT to treat the non-CNS symptoms of Gaucher disease types 1 and 3

Cerezyme is the #1 prescribed ERT for Gaucher disease type 1 in the US*

Cerezyme is the only treatment for Gaucher disease type 1 with over 30 years of time-tested and enduring results. Cerezyme is also the first and only FDA-approved treatment for the non-central nervous system (CNS) symptoms of Gaucher disease type 3.

Indication:
Cerezyme® (imiglucerase) for injection is indicated for the treatment of non-central nervous system (CNS) manifestations of Type 1 or Type 3 Gaucher disease in adult and pediatric patients.  

 

*Based on publicly available data as of September 2025.

CNS=central nervous system; ERT=enzyme replacement therapy; FDA=Food and Drug Administration.

Illustration of a person from Cerezyme® (imiglucerase) logo

About Cerezyme

Cerezyme is the only FDA-approved treatment for both Gaucher disease type 1 and type 3

Learn About Cerezyme
Illustration of an infusion (IV) drip bag

Treating With Cerezyme

What can you expect with Cerezyme treatment?

Learn About Treatment
Illustration of two people talking to each other. A speech bubble with a heart is shown between them to represent support.

Get Support

Receive personalized support through our dedicated team

Get Started With CareConnect

Important Safety Information

WARNING: SEVERE ALLERGIC REACTIONS

Allergic reactions, including severe reactions that may be serious or life-threatening (known as anaphylaxis), have occurred during the early course and after repeated treatment with CEREZYME.

Your healthcare professional should initiate CEREZYME in a healthcare setting with appropriate medical monitoring and support measures. If a severe allergic or anaphylactic reaction occurs, your healthcare professional will immediately stop the infusion and provide appropriate medical treatment.

Seek immediate medical care should symptoms occur.

Cerezyme can cause serious side effects including:

Allergic Reactions (Including Anaphylaxis) and Infusion-Associated Reactions (IARs):

Signs of an allergic reaction reported during or shortly after an infusion included itching, flushing, hives, swelling under the skin, chest discomfort, shortness of breath, coughing, a bluish discoloration of the skin due to diminished oxygen, rapid heart rate, and low blood pressure.

Signs of an infusion reaction included rash, chills, fatigue, infusion-site burning, infusion-site discomfort, or infusion-site swelling, fever, and high blood pressure. Tell your healthcare professional right away if you experience any reactions. Your healthcare professional may slow or stop the infusion or may lower the next dose. Your healthcare professional may decide to give you antihistamine, anti-fever, and/or steroid medications before your infusions and monitor you for new signs and symptoms of a reaction.

Common Side Effects:

  • Common side effects reported in adults and children include back pain, chills, dizziness, fatigue, headache, allergic reactions, nausea, fever, and vomiting.

Please see accompanying Full Prescribing Information, including Boxed WARNING.

Cerezyme® (imiglucerase) for injection is indicated for the treatment of non-central nervous system (CNS) manifestations of Type 1 or Type 3 Gaucher disease in adult and pediatric patients.